Basil Systems Commercial Launch and New Seed Funding

Basil Systems is delighted to announce that our SaaS platform for delivering essential healthcare insights is now commercially available. In addition, we secured $1.5M in venture capital funding to accelerate development and drive our initial market launch.


Susan Alpert, a top regulatory consultant, former SVP of Regulatory Affairs at Medtronic and a former FDA Director, was unequivocal in her enthusiasm for our new platform, saying, "Basil Systems is a game changer!"


The funding round was led by Looking Glass Capital and Golden Ventures.


Read the full press release here.